Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma.

AA patients with NDMM treated in the era of novel agents have greater improvement in renal function in comparison to non-AA patients, regardless of myeloma response. The biological underpinnings for this disparity require further investigation.